FIELD: medicine; oncology.
SUBSTANCE: invention relates to medicine, namely to oncology; it can be used for enhancing tumor cell death. A method includes impact with a drug 1 hour before radiation and radiation of bowel cancer cells with HCT116 dose of 4 Gr. An inhibitor of cyclin-dependent kinases CDK 8/19 Senexin B is used as the drug.
EFFECT: use of the invention allows for the reduction in survivability of tumor cells due to the action of a combination on their survival mechanism and prevention of the formation of resistance under the action of gamma-radiation.
2 cl, 2 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR PREVENTING CHEMORESISTANCE TO ANTIMITOTIC AGENTS | 2022 |
|
RU2807691C1 |
| APPLICATION OF DNA FRAGMENT OF TRANSCRIBED REGION OF RIBOSOMAL REPEAT TO INCREASE STABILITY OF MESENCHIMAL STEM CELLS TO ACTION OF AGGRESSIVE ENVIRONMENTAL FACTORS | 2013 |
|
RU2560270C2 |
| TREATING CANCER WITH COMBINATION OF RADIATION THERAPY, CERIUM OXIDE NANOPARTICLES AND CHEMOTHERAPEUTIC AGENT | 2015 |
|
RU2704811C2 |
| METHOD OF TUMOUR CELLS RADIOSENSITIZATION | 2019 |
|
RU2723393C1 |
| METHOD FOR NON-CONTACT STIMULATION OF TRANSCRIPTIONAL ACTIVITY OF CYCLIN-DEPENDENT KINASE 2 INHIBITOR GENE IN PROSTATE TUMOR CELLS | 2020 |
|
RU2763992C1 |
| SALTS OF 4-((2-(6-(4-METHYLPIPERAZINE-1-CARBONYL)-NAPHTHALEN-2-YL)ETHYL) AMINO)QUINAZOLINE-6-CARBONITRILE AND PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2641001C1 |
| METHOD OF USING 4-((5,10-DIMETHYL-6-OXO-6,10-DIHYDRO-5H-PYRIMIDO[5,4-b]THIENO[3,2-e][1,4]DIAZEPIN-2-YL)AMINO)BENZENESULFONAMIDE (XMU-MP-1) TO INHIBIT GROWTH OF BURKITT'S LYMPHOMA CELLS | 2023 |
|
RU2814013C1 |
| TREATING PANCREATIC CANCER AND NON-SMALL CELL LUNG CANCER WITH ATR INHIBITORS | 2012 |
|
RU2648507C2 |
| BRAF KINASE INHIBITOR N-(3-(5-(4-CHLOROPHENYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-CARBONIL)-2,4-DIFLUOROPHENYL)PROPANE-1-SULFONAMIDE | 2018 |
|
RU2687107C1 |
| CANCER TREATMENT WITH TG02 | 2017 |
|
RU2749025C2 |
